Explore › Outcome › History of surgery for cerebral aneurysm
Outcome

History of surgery for cerebral aneurysm

Also known as: History of cerebral aneurysm surgery History of surgery for cerebral aneurysm History of surgery for cerebral aneurysm (situation) Surgery for mesh complications (mesh removal, revision, exposure)
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
Oversewing of exposed vaginal mesh1
conditions
Anterior vaginal wall prolapse1
populations
Postmenopausal Women1
studys
PMC38940571

Findings (27)

None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →
None
adverse

Vaginal mesh augmentation carried a 5.9% 5-year risk of surgery for mesh complications (vs 0.7% in native tissue, p<0.0001; adjusted HR 8.21, 95%CI 6.31-10.67), with the risk increasing over calendar

Effect: adverse; HR 8.21; CI: 95%CI 6.31, 10.67

Size: HR 8.21 CI: 95%CI 6.31, 10.67
PMC3894057
Finding details → · Paper → · Graph →

Papers (1)